The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
about
Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXRLipidome in colorectal cancerBile acids, obesity, and the metabolic syndromeFatty liver diseases, bile acids, and FXRBile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver DiseaseBile acid nuclear receptor FXR and digestive system diseasesDiacylglycerol kinase θ couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytesFarnesoid X receptor regulates bile acid-amino acid conjugationBile acid signaling in metabolic disease and drug therapyThe orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoterPhospholipase D2 mediates signaling by ATPase class I type 8B membrane 1The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in miceFarnesoid X receptor is essential for normal glucose homeostasisAgeing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASHFXR promotes endothelial cell motility through coordinated regulation of FAK and MMP-9.Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene.Bile acid sequestrants for lipid and glucose control.Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia.New developments in selective cholesteryl ester uptake.Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner.Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitusProtective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signalNutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome.Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes modelFarnesoid X receptor induces murine scavenger receptor Class B type I via intron binding.Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease.Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.Tissue specific induction of p62/Sqstm1 by farnesoid X receptor.The extended TILAR approach: a novel tool for dynamic modeling of the transcription factor network regulating the adaption to in vitro cultivation of murine hepatocytes.Deciphering the nuclear bile acid receptor FXR paradigm.Tissue-specific function of farnesoid X receptor in liver and intestineDevelopment of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discoveryStudies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptorMelanocortin signaling in the CNS directly regulates circulating cholesterol.Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice.MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor.Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.Effects of FXR in foam-cell formation and atherosclerosis development.Nuclear receptors in nonalcoholic Fatty liver disease
P2860
Q24623871-D428E1D5-6E6F-46E8-9771-2B40361A9E05Q26766296-B4C9BA30-C310-4991-B93A-F498D10D7FEEQ27020976-3CD3C59C-8766-4F51-816D-90B35C0C2B49Q28068199-463388EC-1AD1-4273-B877-ED98553A1991Q28076064-A45D2B25-3C54-4644-B9C9-1A0F51EB7189Q28085493-6CD06A6A-DD79-476B-81D8-EFB494EF825CQ28114796-71DB4545-AF52-4BC5-A6EA-12123AB1C101Q28204827-89CAD2CC-39FD-4D7D-9F56-A0695A06A2E4Q28244875-E717D9E2-D365-468E-94B7-35735E62B826Q28259634-D5B03BDA-8235-4561-A471-511CAAB9A4CCQ28395197-7AF8A82F-081B-48D7-8194-15BF12D445D6Q28587753-213E96F7-8C8D-41C8-A307-3310A708C0E8Q28591952-526EF845-65B7-4DA8-AD27-FFFD3ED1D884Q30454451-9DF3B6AC-49B2-4054-BC59-D882A194461EQ30488268-1640C029-B26A-46F8-AC20-C66373C5389CQ33243916-588C0478-3CCC-4B2F-B2CE-118F50B56924Q33651272-8BA94354-A881-49F6-B8DA-5D1AE9F4D48DQ33661459-CDE3A638-236F-4F99-848B-F5D99297640CQ33894679-950D1912-10F3-4418-9AD7-22A286112974Q33993688-38D4E006-1261-47A7-9727-049C064DF8DAQ34081372-9C833327-9BDC-4BAC-B212-F37F253C5DEEQ34098522-BF8417F2-6794-4EDD-8202-DB97F574107AQ34193332-8DEC439C-AAD2-446B-A18D-BF778450D060Q34237738-43200437-ECA8-4C08-90C5-A5259D4AE59DQ34249416-7D2BF1BD-CDE0-4701-ACE0-215396108867Q34303001-9BC75F61-34C6-4DAB-83C8-9B63D73F1ADEQ34310071-A484C8D2-652D-4B53-B9D9-E24140B27B71Q34405939-733F5B51-645A-429E-81EB-0A879BCF749BQ34494671-FF5ECD68-F84D-4FC0-970D-F7D20E8520BAQ34626518-05801637-821B-4DD4-930B-3B36ED25F9E1Q34714107-BC8D5B74-466C-43A1-96CE-15D65F2E0B77Q34729209-4BEACD18-E890-4B15-8C83-00249440E1ACQ34955918-D298EDD0-3F24-4734-9E6E-FC1139FF99C5Q34999515-7AE915CD-27B6-43A5-BFAC-FCC89341D836Q35063271-32756331-11E0-48A9-BBCD-76418D9757ABQ35077956-5F8F1D2D-5987-4154-AA8E-7E7024568CDAQ35173008-9AD76483-C65B-4227-AF3E-D54EEDB4E16BQ35204411-BC78C17F-356B-4E2B-AA85-AACE77AEBF9FQ35546179-04BC23AC-DB04-4C2F-8566-FF69155D43EDQ35609154-D1C28F4E-108F-4D8D-A142-81F9A11CB942
P2860
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
description
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2003
@ast
im Januar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/01/24)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/01/24)
@nl
наукова стаття, опублікована в січні 2003
@uk
name
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@ast
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@en
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@nl
type
label
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@ast
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@en
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@nl
prefLabel
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@ast
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@en
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@nl
P2093
P2860
P3181
P356
P1476
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
@en
P2093
Christopher J Sinal
Frank J Gonzalez
H Bryan Brewer
Marcelo J A Amar
P2860
P304
P3181
P356
10.1074/JBC.M209525200
P407
P577
2002-11-05T00:00:00Z